Reemergence of neural crest stem cell-like states in melanoma during disease progression and treatment. (1st December 2020)

• Record Type: Journal Article
• Authors: Diener, Johanna; Sommer, Lukas
• Is Part Of: Stem cells translational medicine. Volume 10:Number 4(2021)
• Page Start: 522
• Page End: 533
• Publication Date: 2020-12-01
• Subjects: cancer -- development -- drug resistance -- invasion -- melanoma -- neural crest stem cells (NCSCs) -- tumor initiation; Stem cells -- Periodicals; Regenerative medicine -- Periodicals; Periodicals; 616.0277405
• DOI: 10.1002/sctm.20-0351
• Languages: English
• ISSNs: 2157-6564

Abstract

Abstract: Melanoma is the deadliest of all skin cancers due to its high metastatic potential. In recent years, advances in targeted therapy and immunotherapy have contributed to a remarkable progress in the treatment of metastatic disease. However, intrinsic or acquired resistance to such therapies remains a major obstacle in melanoma treatment. Melanoma disease progression, beginning from tumor initiation and growth to acquisition of invasive phenotypes and metastatic spread and acquisition of treatment resistance, has been associated with cellular dedifferentiation and the hijacking of gene regulatory networks reminiscent of the neural crest (NC)—the developmental structure which gives rise to melanocytes and hence melanoma. This review summarizes the experimental evidence for the involvement of NC stem cell (NCSC)-like cell states during melanoma progression and addresses novel approaches to combat the emergence of stemness characteristics that have shown to be linked with aggressive disease outcome and drug resistance.